<code id='E40239D466'></code><style id='E40239D466'></style>
    • <acronym id='E40239D466'></acronym>
      <center id='E40239D466'><center id='E40239D466'><tfoot id='E40239D466'></tfoot></center><abbr id='E40239D466'><dir id='E40239D466'><tfoot id='E40239D466'></tfoot><noframes id='E40239D466'>

    • <optgroup id='E40239D466'><strike id='E40239D466'><sup id='E40239D466'></sup></strike><code id='E40239D466'></code></optgroup>
        1. <b id='E40239D466'><label id='E40239D466'><select id='E40239D466'><dt id='E40239D466'><span id='E40239D466'></span></dt></select></label></b><u id='E40239D466'></u>
          <i id='E40239D466'><strike id='E40239D466'><tt id='E40239D466'><pre id='E40239D466'></pre></tt></strike></i>

          hotspot

          hotspot

          author:Wikipedia    Page View:1
          Stock Market
          APStock

          Introducing STAT’s Biotech Q2 Scorecard, our emoji-enabled means of tracking 12 make-or-break events expected over the next three months.

          When each clinical trial or FDA decision crosses the wires, we’ll add in the appropriate rocket ship, grimace face, bulging bicep or broken heart — whatever captures the mood.

          advertisement

          Read on for brief explanations of what we’re watching for from each company.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          Stories you might have missed in 2023: health, science, medicine
          Stories you might have missed in 2023: health, science, medicine

          Oneofourfavoritestoriesfeaturedoneofourfavoriteillustrations.MikeReddyforSTATThere’sanoldstoryinjour

          read more
          George Santos makes 1st court appearance after pleading not guilty to 13 counts
          George Santos makes 1st court appearance after pleading not guilty to 13 counts

          1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

          read more

          Merck to acquire Harpoon Therapeutics for $680 million

          MelEvans/APMerckannouncedMondayitwillacquireHarpoonTherapeuticsanditspipelineofimmune-basedcancerdru